Loading market dashboard
Thermo Fisher Scientific Inc.
TMOHealthcareNYSEUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Thermo Fisher Scientific Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $58.18B | $57.18B - $58.75B | $15.88B | $37.783 | 7 |
| Dec 2029 | $56.47B | $55.49B - $57.02B | $15.41B | $33.783 | 11 |
| Dec 2028 | $53.54B | $53.50B - $53.57B | $14.61B | $30.001 | 15 |
| Dec 2027 | $50.36B | $48.93B - $51.11B | $13.75B | $27.201 | 19 |
| Dec 2026 | $47.77B | $46.85B - $48.16B | $13.04B | $24.862 | 18 |
| Dec 2025 | $44.29B | $44.21B - $44.35B | $12.09B | $22.745 | 18 |
| Dec 2024 | $42.77B | $42.60B - $42.88B | $11.68B | $21.702 | 17 |
| Dec 2023 | $42.35B | $41.61B - $42.76B | $11.56B | $16.198 | 8 |
| Dec 2022 | $43.88B | $43.39B - $44.14B | $7.89B | $23.037 | 7 |
| Dec 2021 | $37.26B | $36.84B - $37.48B | $10.59B | $23.541 | 16 |
| Dec 2020 | $31.12B | $30.77B - $31.30B | $8.55B | $19.029 | 12 |
| Dec 2019 | $25.49B | $25.20B - $25.64B | $6.90B | $12.332 | 7 |